targeting-ace2-for-treatments

Targeting ACE2 for treatments of COVID-19

ACE2 is a membrane protein with an enzymatic domain located on the outer surface of human cells and is the primary target and receptor for the SARS-CoV-2 virus that causes COVID-19.

While many treatments and cures are seeking to address the virus itself, some researchers are intent to find ways to exploit the ACE2 and prevent the spread of Coronavirus ACE2 play a crucial role in host cell invasion by SARS-CoV-2 and efforts are underway to develop drugs that can block its function in this capacity.

Related CAS Insights

Drug Discovery

A review of the global efforts on COVID-19 vaccine development

March 29, 2021

Read article
Drug Discovery

ACE2: Targeting a potentially important receptor in disease pathogenesis

December 15, 2022

Read article
Drug Discovery

ACS webinar on molecular glues and targeted protein degradation

October 12, 2022

Read article

Gain new perspectives for faster progress directly to your inbox.